OECD and Europol issue COVID-19 counterfeits warning

The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the Organisation for Economic Co-operation and Development (OECD) and the European Union Intellectual Property Office (EUIPO).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

US customs raids find thousands of fake COVID-19 test kits

5 May 2020 US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.

Africa

US companies hit hardest by fake medicines: EUIPO, OECD

24 March 2020 Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.

Big Pharma

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

More on this story

Americas

US customs raids find thousands of fake COVID-19 test kits

5 May 2020 US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.

Africa

US companies hit hardest by fake medicines: EUIPO, OECD

Big Pharma

Counterfeiters exploiting COVID-19 outbreak: MHRA

More on this story

Americas

US customs raids find thousands of fake COVID-19 test kits

5 May 2020 US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.

Africa

US companies hit hardest by fake medicines: EUIPO, OECD

Big Pharma

Counterfeiters exploiting COVID-19 outbreak: MHRA